Archive: 2006 Early-Stage Life Sciences Technology Conference II
May 1, 2006, 12:45-7:00 pm
The Conference Center at Harvard Medical School
77 Avenue Louis Pasteur, Boston , MA
Conference Description
Presenters and Exhibitors include BioBehavioral Diagnostics, Contego Pharmaceuticals, P.A. Technologies, and Perfusion Technology as well as emerging companies and new technologies from Massachusetts General Hospital , University of Massachusetts Lowell , Harvard Medical School , Northeastern University , University of Massachusetts Amherst , University of Massachusetts Medical School, and Beth Israel Deaconess Medical Center.
Keynote Speaker: Prof. Phillip Zamore Ph.D., UMass Medical School.
Conference Highlights:
Keynote Speaker: Prof. Phillip Zamore Ph.D., UMass Medical School. Phil Zamore, a professor at UMass Medical School and a scientific co-founder of Alnylam will discuss the impact of RNAi both in the lab and in industry. RNAi technology, which Science Magazine called the Breakthrough of the Year in 2002, is a novel technology that can shut down the ability of a specific gene to express. The technology is being used extensively as a research tool to determine how genes work and has huge commercial applications as the basis of new therapeutics. Dr. Zamore was an author and a major contributor to a seminal work between MIT, UMass Medical School and the Max Plank Institute. He continues to be research leader in this field.
Formal company presentations: There will be formal presentations by a select group of early-stage spin-off companies and faculty seeking their first round of professional investment.
Reception and poster session: A networking reception will include poster presentations by all of the presenting companies and by additional institutions and incubating companies.
Agenda:
12:45 - 1:15 Registration and Dessert Bar
1:15 - 2:15 Welcome: Abi Barrow, Director of Massachusetts Technology Transfer Center, Conference Host
Keynote: Prof. Phillip Zamore, UMass Medical School and co-founder of Alnylam.
2:15 - 2:30 Mass Tech Portal Launch
2:30 - 3:15 Company presentations - Session One
Meiogen Biotechnology Corporation
Harvard Medical School , Jose Halperin
P.A. Technologies, LLC
Encapsion
3:15 - 3:30 Coffee Break
3:30 - 5:00 Company presentations - Session Two
SomRx, Inc
IGAN Therapeutics, Inc.
BioBehavioral Diagnostics
Perfusion Technology LLC
University of Massachusetts Medical School
Contego Pharmaceuticals
Northeastern University
Enhanced Medical Systems
5:00 - 7:00 Networking Reception and Poster Session
Sponsorship Information:
$3,000 Sponsorships Available
Sponsorship benefits:
- Two complementary conference registrations
- Recognition in pre-event advertising
- Designation as sponsor in event signage
- Opportunity to display sponsor literature on literature table
- Name and/or logo on printed conference materials and Web site
- One-page service description and contact information in conference book
- Acknowledgment and thanks at beginning of meeting
- Early notification of sponsorship opportunities for future events
Speaker Bio
Prof. Phillip Zamore
Ph.D.
UMass Medical School
Phil Zamore, a professor at UMass Medical School and a scientific co-founder of Alnylam will discuss the impact of RNAi both in the lab and in industry. RNAi technology, which Science Magazine called the Breakthrough of the Year in 2002, is a novel technology that can shut down the ability of a specific gene to express. The technology is being used extensively as a research tool to determine how genes work and has huge commercial applications as the basis of new therapeutics. Dr. Zamore was an author and a major contributor to a seminal work between MIT, UMass Medical School and the Max Plank Institute. He continues to be research leader in this field.